These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 21889518)

  • 21. GABA regulates the rat hypothalamic-pituitary-adrenocortical axis via different GABA-A receptor alpha-subtypes.
    Mikkelsen JD; Bundzikova J; Larsen MH; Hansen HH; Kiss A
    Ann N Y Acad Sci; 2008 Dec; 1148():384-92. PubMed ID: 19120132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABAB receptors and depression. Current status.
    Cryan JF; Slattery DA
    Adv Pharmacol; 2010; 58():427-51. PubMed ID: 20655491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
    Rezvanfard M; Zarrindast MR; Bina P
    Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023.
    Atack JR
    Adv Pharmacol; 2009; 57():137-85. PubMed ID: 20230761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the γ-aminobutyric acid (GABA) system by Passiflora incarnata L.
    Appel K; Rose T; Fiebich B; Kammler T; Hoffmann C; Weiss G
    Phytother Res; 2011 Jun; 25(6):838-43. PubMed ID: 21089181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytics: past, present, and future agents.
    Nemeroff CB
    J Clin Psychiatry; 2003; 64 Suppl 3():3-6. PubMed ID: 12662127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
    Mirza NR; Larsen JS; Mathiasen C; Jacobsen TA; Munro G; Erichsen HK; Nielsen AN; Troelsen KB; Nielsen EØ; Ahring PK
    J Pharmacol Exp Ther; 2008 Dec; 327(3):954-68. PubMed ID: 18791063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amygdalar orexinergic-GABAergic interactions regulate anxiety behaviors of the Syrian golden hamster.
    Avolio E; Alò R; Carelli A; Canonaco M
    Behav Brain Res; 2011 Apr; 218(2):288-95. PubMed ID: 21074570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activin tunes GABAergic neurotransmission and modulates anxiety-like behavior.
    Zheng F; Adelsberger H; Müller MR; Fritschy JM; Werner S; Alzheimer C
    Mol Psychiatry; 2009 Mar; 14(3):332-46. PubMed ID: 18180762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABA systems, benzodiazepines, and substance dependence.
    Malcolm RJ
    J Clin Psychiatry; 2003; 64 Suppl 3():36-40. PubMed ID: 12662132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From ion currents to genomic analysis: recent advances in GABAA receptor research.
    Rabow LE; Russek SJ; Farb DH
    Synapse; 1995 Nov; 21(3):189-274. PubMed ID: 8578436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GABA homeostasis contributes to the developmental programming of anxiety-related behavior.
    Depino AM; Tsetsenis T; Gross C
    Brain Res; 2008 May; 1210():189-99. PubMed ID: 18407251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
    Tsuji M; Miyagawa K; Takeuchi T; Takeda H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test.
    Mathiasen LS; Rodgers RJ; Mirza NR
    Behav Pharmacol; 2007 May; 18(3):191-203. PubMed ID: 17426483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depressive-like behavior induced by tumor necrosis factor-α in mice.
    Kaster MP; Gadotti VM; Calixto JB; Santos AR; Rodrigues AL
    Neuropharmacology; 2012 Jan; 62(1):419-26. PubMed ID: 21867719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock.
    Lloyd KG; Thuret F; Pilc A
    J Pharmacol Exp Ther; 1985 Oct; 235(1):191-9. PubMed ID: 2995646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.